Control of immunity by the TNFR-related molecule OX40 (CD134)
about
Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) BiologyNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyNanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityAutoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsModulation of GITR for cancer immunotherapyScience gone translational: the OX40 agonist storyForsythoside A Inhibits BVDV Replication via TRAF2-Dependent CD28–4-1BB Signaling in Bovine PBMCsRegulators of Tfh Cell DifferentiationT cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccinationMouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cellsDual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expressionp38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γMolecular control of Tfh-cell differentiation by Roquin family proteins.OX40 facilitates control of a persistent virus infection.Distinct host cell proteins incorporated by SIV replicating in CD4+ T cells from natural disease resistant versus non-natural disease susceptible hostsAntigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cellsAberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma.OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4.Regulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity.Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interactionRoscovitine suppresses CD4+ T cells and T cell-mediated experimental uveitis.PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer.OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infectionDecreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunityTechnical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation.CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patientsAgonist antibodies to TNFR molecules that costimulate T and NK cellsActivation of OX40 prolongs and exacerbates autoimmune experimental uveitisTNF superfamily protein-protein interactions: feasibility of small- molecule modulationRole of co-stimulation in LeishmaniasisNF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice
P2860
Q26752599-D62922D2-F432-41BD-8A86-0826BFD3D30DQ26772347-857BCC96-D36E-4532-A501-AA992256F712Q26782566-FF558A6C-3A85-4778-91F2-443A0F924D46Q26800155-BD17E938-32C1-4650-B557-4854CC490C11Q26823789-9F73C22D-1292-45F5-91A8-45C07BC67165Q26853557-EA638EF4-2965-4815-8CFF-5506DE603F89Q27022436-E24DE127-9063-436F-B642-CCE9EAE9CCDBQ27468726-D3F078F7-FF5B-44DB-8800-4DB92DBE9515Q28072283-543E1E8B-AF2C-478B-8498-02D913FB7E95Q28274469-9A46D0A5-2A03-4A32-8768-9D91CBCD8DAEQ28302789-E896435A-3924-4582-AE6A-C54E1E56478DQ28730751-CDD8E210-DDF0-4CBB-A874-C4EFC0B5B91FQ30422500-078463AA-ECD3-49CC-B200-66EB2824B3FEQ31108462-AE31D2A4-BEEC-4AF0-8409-A1DF969BB0C1Q33610214-0ED08FFE-327F-425B-8257-4C18D89FA216Q33617937-396C905D-3FCB-48AF-8C2F-3D4CE32E32C7Q33886711-AFADB8E5-6EFD-47EC-9F0A-5490581899CDQ34336633-53203751-4357-4E99-892F-0A2B61335B54Q34411863-E04E9623-3756-4857-B6D7-38BB3005C2CAQ34451035-CDEE3F21-61E4-4C5C-89D4-F964DA00238BQ34582700-71078A0D-7AD6-4C33-B613-E65127E9CBD6Q34704329-771F911B-CC7F-45A0-924D-AABF27F1B6D7Q34707183-5F935111-2B29-477D-A326-E9CCDAEFFC3BQ34749303-5E65F6AC-79B7-4410-AA5F-4A43AC9B9B84Q34845661-2883C1F9-494F-4C14-8B0D-9B351F98B141Q34926132-EADF9A51-2368-40F7-AAC4-7BD654050835Q34954124-2FE4A04D-BC6F-42BE-8DC3-0B5A894ECB1FQ35049475-5297D61B-3E72-4759-9022-7B30A1FF85ADQ35107110-1D012599-13F0-424D-9AC2-FA453FF36D48Q35118177-FA0B0EBC-91A3-4346-8D4F-0B29C1EF994CQ35193006-D13064E7-0F2F-455A-8761-5D597D664C99Q35224581-45518BAA-0375-412A-8C02-04F5ABEE2109Q35225350-3F439115-5611-4EF7-94E0-F0AB900BEF23Q35228053-5A13D1B4-80FF-4298-A10B-982694D7C4D3Q35298711-11D0483D-B026-42B3-9A17-355B627B4E82Q35427446-D1D08DC8-2B4F-4F70-A90C-B98821B550D2Q35524673-B13D0AE7-8BA3-4BCD-A54A-DA1F3B9E680EQ35534271-15E4E388-71D4-413B-A187-3492BDC7234FQ35566850-57D0C078-3793-4BDC-887B-64A3EA4DDE48Q35570169-27DF5A64-1F39-46FC-BECD-034DA50EBEE0
P2860
Control of immunity by the TNFR-related molecule OX40 (CD134)
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Control of immunity by the TNFR-related molecule OX40 (CD134)
@ast
Control of immunity by the TNFR-related molecule OX40 (CD134)
@en
type
label
Control of immunity by the TNFR-related molecule OX40 (CD134)
@ast
Control of immunity by the TNFR-related molecule OX40 (CD134)
@en
prefLabel
Control of immunity by the TNFR-related molecule OX40 (CD134)
@ast
Control of immunity by the TNFR-related molecule OX40 (CD134)
@en
P2860
P1476
Control of immunity by the TNFR-related molecule OX40 (CD134)
@en
P2093
Michael Croft
P2860
P356
10.1146/ANNUREV-IMMUNOL-030409-101243
P577
2010-01-01T00:00:00Z